Winton Capital »

Rapport Therapeutics shares owned by Winton Capital

Quarter-by-quarter ownership of Rapport Therapeutics (RAPP) shares owned by Winton Capital from 13F filings

Historical chart of Winton Capital investment in Rapport Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Rapport Therapeutics held by Winton Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rapport Therapeutics by Winton Capital

Quarter filed Position value Share count Share price at filing
2024-09-30 $494k 24k 20.48